Tri-city study of Ecstasy use problems: A latent class analysis

Drug and Alcohol Dependence

Volumn 98, Issue 3, 2008, Pages 249-263

  Scheier, Lawrence M ^a,b   Abdallah, Arbi Ben ^b   Inciardi, James A ^c   Copeland, Jan ^d   Cottler, Linda B ^b  

^a LARS Research Institute Inc   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF DELAWARE   (United States)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Abuse; Dependence; Ecstasy; Latent class analysis; Substance use disorders

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CLUSTER ANALYSIS; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DRUG DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SUBSTANCE ABUSE; UNITED STATES;

ADULT; AMPHETAMINE-RELATED DISORDERS; DEPRESSION; FAMILY; FEMALE; HALLUCINOGENS; HUMANS; LOGISTIC MODELS; MALE; MODELS, STATISTICAL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHIATRIC STATUS RATING SCALES; RELIGION; RISK ASSESSMENT; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 53049094353     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.06.008     Document Type: Article

References (95)

1. Adlaf E.M., and Smart R.G. Party subculture or dens of doom? An epidemiological study of rave attendance and drug use patterns among adolescent students. J. Psychoactive Drugs 29 (1997) 193-198
2. Akaike H. Likelihood of a model and information criteria. J. Econ. 16 (1981) 3-14
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. (1980), American Psychiatric Association, Washington, DC
4. Anthony J.C., and Helzer J. Syndromes of drug abuse and dependence. In: Robins L.N., and Regier D.A. (Eds). Psychiatric Disorders in America: The ECA study (1991), The Free Press, New York 116-154
5. Basu D., Ball S.A., Feinn R., Gelernter J., and Kranzler H.R. Typologies of drug dependence: comparative validity of a multivariate and four univariate models. Drug Alcohol Depend. 73 (2004) 289-300
6. Battaglia G., Yeh S.Y., and De Souza E.B. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol. Biochem. Behav. 29 (1988) 269-274
7. Beck J. The public health implications of MDMA use. In: Peroutka S.J. (Ed). Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA (1990), Kluwer, Boston 77-103
8. Bhattachary S., and Powell J. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment. Psychol. Med. 31 (2001) 647-658
9. Bolla K.I., McCann U.D., and Ricaurte G.A. Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology 51 (1998) 1532-1537
10. Bryant K.J., Rounsaville B.J., and Babor T.F. Coherence of the dependence syndrome in cocaine users. Br. J. Addict. 86 (1991) 1299-1310
11. Bucholz K., Hesselbrock V., Heath A., Kramer J., and Schuckit M. A latent class analysis of antisocial personality disorder symptom data from a multi-centre family study of alcoholism. Addiction 95 (2000) 553-567
12. Carlson R.G., Wang J., Falck R.S., and Siegal H.A. Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis. Drug Alcohol Depend. 79 (2005) 167-179
13. Chick J. Is there a unidimensional alcohol dependence syndrome?. Br. J. Addict. 75 (1980) 265-280
14. Clogg C.C. Latent class models. In: Arminger G., Clogg C.C., and Sobel M.E. (Eds). Handbook of Statistical Modeling for the Social and Behavioral Sciences (1995), Plenum Press, New York 311-359
15. Cohen R.S. The Love Drug - Marching to the Beat of Ecstasy (1998), Haworth Medical Press, New York
16. Cole J.C., and Sumnall H.R. Altered states: the clinical effects of Ecstasy. Pharmacol. Ther. 98 (2003) 35-58
17. Collins L.M., Graham J.W., Long J.D., and Hansen W.B. Cross-validation of latent class models of early substance use onset. Mult. Behav. Res. 29 (1994) 165-183
18. Cottler L.B., and Keating S.K. Operationalization of alcohol and drug dependence criteria by means of a structured interview. Recent Dev. Alcohol. 8 (1990) 69-83
19. Cottler L.B., Schuckit M.A., Helzer J.E., Crowley T., Woody G., Nathan P., and Hughes J. The DSM-IV field trial for substance use disorders: major results. Drug Alcohol Depend. 38 (1995) 59-69
20. Cottler L.B., Womack S.B., Compton W.M., and Ben-Abdallah A. Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Hum. Psychopharmacol. 16 (2001) 599-606
21. Crum R.M., Storr C.L., and Chan Y.-F. Depression syndromes with risk of alcohol dependence in adulthood: a latent class analysis. Drug Alcohol Depend. 79 (2005) 71-81
22. Curran H.V., and Travill R.A. Mood and cognitive effects of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): weekend "high" followed by mid-week low. Addiction 92 (1997) 821-831
23. Davidson R., Bunting B., and Raistrick D. The homogeneity of the alcohol dependence syndrome: a factorial analysis of the SADD questionnaire. Br. J. Addict. 84 (1989) 907-915
24. Davison D., and Parrott A.C. Ecstasy in recreational users: self-reported psychological and physiological effects. Hum. Psychopharmacol. 12 (1997) 91-97
25. Edwards G., and Gross M.M. Alcohol dependence: provisional description of a clinical syndrome. Br. Med. J. 1 (1976) 1058-1061
26. Gamma A., Jerome L., Liechti M.E., and Sumnall H.R. Is ecstasy perceived to be safe? A critical survey. Drug Alcohol Depend. 77 (2005) 185-193
27. Garrett E.S., and Zeger S.L. Latent class model diagnosis. Biometrics 56 (2000) 1055-1067
28. Gerra G., Zaimovic A., Ferri M., Zambelli U., Timpano M., Neri E., Marzocchi G.F., Delsignore R., and Brambilla F. Long-lasting effects of 3,3-methylenedioxymethamphetamine (Ecstasy) on serotonin system function in humans. Biol. Psychiatry 47 (2000) 127-136
29. Gerra G., Zaimovic A., Giucastro G., Maestri D., Monica C., Sartori R., Caccavari R., and Delsignore R. Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('Ecstasy') in humans. Int. Clin. Psychopharmacol. 13 (1998) 1-9
30. Gold M.S., and McKewen M. Trends in hallucinogenic drug use: LSD, "ecstasy," and the rave phenomenon. Dir. Psychiatry 15 (1995) 1-7
31. Goodman L.A. Exploratory latent structure analysis using both identifiable and unidentifiable models. Biometrika 61 (1974) 215-231
32. Gouzoulis-Mayfrank E., Daumann J., Tuchtenhagen F., Pelz S., Becker S., Kunert H.-K., Fimm B., and Sass H. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J. Neurol. Neurosurg. Psychiatry 68 (2000) 719-725
33. Grant J.D., Scherrer J.F., and Lyons M.J. Subjective reactions to cocaine and marijuana are associated with abuse and dependence. Addict. Behav. 30 (2005) 1574-1586
34. Greer G. Using MDMA in psychotherapy. Advances 2 (1985) 57-62
35. Greer G., and Tolbert R. The therapeutic use of MDMA. In: Peroutka S.J. (Ed). Ecstasy: The Clinical, Pharmacological, and Neurotoxicological Effects of the Drug MDMA (1990), Kluwer Academic Publishers, Boston 21-36
36. Haberman S.J. Analysis of quantitative data. New developments vol. 2 (1979), Academic Press, New York
37. Hagenaars J.A. Latent structure models with direct effects between indicators: local dependence models. Sociol. Methods Res. 16 (1988) 379-405
38. Hammersley R., Ditton J., Smith I., and Short E. Patterns of ecstasy use by drug users. Br. J. Crim. 39 (1999) 625-647
39. Harford T.C., and Muthén B.O. The dimensionality of alcohol abuse and dependence: a multivariate analysis of DSM-IV symptom items in the National Longitudinal Survey of Youth. J. Stud. Alcohol. 62 (2001) 150-157
40. Hasin D., and Paykin A. Dependence symptoms but no diagnosis: diagnostic 'orphans' in a community sample. Drug Alcohol Depend. 50 (1998) 19-26
41. Hosmer D.W., and Lemeshow S. Applied Logistic Regression. 2nd ed. (2000), John Wiley & Sons, New York
42. Jansen K.L. Ecstasy (MDMA) dependence. Drug Alcohol Depend. 53 (1998) 121-124
43. Kalant H. The pharmacology and toxicology of 'ecstasy' (MDMA) and related drugs. Can. Med. Assoc. J. 165 (2001) 917-928
44. Kass R., and Raftery A.E. Bayes factors. J. Am. Stat. Assoc. 90 (1995) 773-795
45. Kish S.J. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?. Pharmacol. Biochem. Behav. 71 (2002) 845-855
46. Kokkevi A., Loukadakis M., Plagianakou S., Politikou K., and Stefanis C. Sharp increase in illicit drug use in Greece: trends from a general population survey on licit and illicit drug use. Eur. Addict. Res. 6 (2000) 42-49
47. Kosten T.R., Rounsaville B.J., Babor T.F., Spitzer R.L., and Williams J.B. Substance-use disorders in DSM-III-R: evidence for the dependence syndrome across different psychoactive substances. Br. J. Psychol. 151 (1987) 834-843
48. Kotz, S., Johnson, N.L. (Eds.), 2006. Encyclopedia of Statistical Sciences, John Wiley & Sons, New York, doi:10.1002/0471667196.ess1912.pub2. Last accessed on July 17, 2008.
49. Krystal J., and Price L. Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?. Am. J. Drug Alcohol Abuse 18 (1992) 331-334
50. Lenton S., Boys A., and Norcross K. Raves, drugs and experience: drug use by a sample of people who attend raves in Western Australia. Addiction 92 (1997) 1327-1337
51. Lyttle T., and Montagne M. Drugs, music and ideology: a social pharmacological interpretation of the Acid House Movement. Int. J. Addict. 27 (1992) 1159-1177
52. MacInnes N., Handley S.L., and Harding G.F. Former chronic methylenedioxymethampetamine (MDMA or ecstasy) users report mild depressive symptoms. J. Psychopharmacol. 15 (2001) 181-186
53. McCann U.D., Ridenour A., Shaham Y., and Ricaurte G.A. Serotonin neurotoxicity after (±)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. Neuropsychopharmacology 10 (1994) 129-138
54. McCutcheon A.L. Latent Class Analysis (1987), Sage Publications, Beverly Hills, CA
55. McGuire P.K., Cope H., and Fahy T.A. Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy'). Br. J. Psychiatry 165 (1994) 391-395
56. Merrill J. Ecstasy and neurodegeneration. Br. Med. J. 313 (1996) 423
57. Morgan M.J. Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology 141 (1999) 30-36
58. Morgan M.J., McFie L., Fleetwood L.H., and Robinson J.A. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?. Psychopharmacology 159 (2002) 294-303
59. Muthén B.O., Grant B., and Hasin D. The dimensionality of alcohol abuse and dependence: factor analysis of the DSM-III-R and proposed DSM-IV criteria in the 1988 National Health Interview Survey. Addiction 88 (1993) 1079-1090
60. National Institute on Drug Abuse, 1993. Risk Behavior Assessment, 3rd ed. Author, Rockville.
61. Nylund K.L., Asparohhov T., and Muthén B.O. Deciding on the number of classes in latent class analysis and growth mixture models: a Monte Carlo simulation study. Struct. Equat. Model. 14 (2007) 535-569
62. Parrott A.C. MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy: the neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology 50 (2004) 329-335
63. Parrott A.C. Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol. Biochem. Behav. 71 (2002) 837-844
64. Parrott A.C., Buchanan T., Scholey A.B., Heffernan T., Ling J., and Rodgers J. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum. Psychopharmacol. 17 (2002) 309-312
65. Parrott A.C., and Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during, and after a Saturday night dance. Psychopharmacology 139 (1998) 261-268
66. Parrott A.C., Lees A., Garnham N.J., Jones M., and Wesnes K. Cognitive performance in recreational users of MDMA of 'Ecstasy': evidence for memory deficits. J. Psychopharmacol. 12 (1998) 79-83
67. Parrott A.C., Sisk E., and Turner J.J. Psychobiological problems in heavy "ecstasy" (MDMA) polydrug users. Drug Alcohol Depend. 60 (2000) 105-110
68. Pederson W., and Skrondal A. Ecstasy and new patterns of drug use: a normal population study. Addiction 94 (1999) 1695-1706
69. Petrides, A., Sherlock, K., 1996. How much ecstasy do the British really take? Mixmag, July 1996.
70. Pollack N.K., and Martin C.S. Diagnostic orphans: adolescents with alcohol symptoms who do not qualify for DSM-IV Abuse or dependence diagnoses. Am. J. Psychol. 156 (1999) 897-901
71. Radloff L.S. The CES-D Scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977) 385-401
72. Reboussin B.A., and Anthony J.C. Is there epidemiological evidence to support the idea that a cocaine dependence syndrome emerges soon after onset of cocaine use?. Neuropsychopharmacology 31 (2006) 2055-2064
73. Rodgers J. Cognitive performance amongst recreational users of "ecstasy". Psychopharmacology 151 (2000) 19-24
74. Roeder K., Lynch K.G., and Nagin D.S. Modeling uncertainty in latent class membership: a case study in criminology. J. Am. Stat. Assoc. 94 (1999) 766-776
75. Roiser J.P., and Sahakian B.J. Relationship between ecstasy use and depression: a study controlling for poly-drug use. Psychopharmacology 173 (2004) 411-417
76. Rounsaville B.J., Spitzer R.L., and Williams J.B.W. Proposed changes in DSM-III substance use disorders: description and rationale. Am. J. Psychiatry 143 (1986) 463-468
77. Sarr M., Bucholz K.K., and Phelps D.L. Using cluster analysis of alcohol use disorders to investigate 'diagnostic orphans': subjects with alcohol dependence symptoms but no diagnosis. Drug Alcohol Depend. 60 (2000) 295-302
78. Schifano F., Di Furia L., Forza G., Minicuci N., and Bricolo R. MDMA ("ecstasy") consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend. 52 (1998) 85-90
79. Scholey A.B., Parrott A.C., Buchanan T., Heffernan T.M., Ling J., and Rodgers J. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Addict. Behav. 29 (2004) 743-752
80. Schwartz R.H., and Miller N.S. MDMA (Ecstasy) and the rave: a review. Pediatrics 100 (1997) 705-708
81. Schwarz G. Estimating the dimension of a model. Ann. Stat. 6 (1978) 461-464
82. Strassman R.J. Hallucinogenic drugs in psychiatric research and treatment. J. Nerv. Ment. Dis. 183 (1995) 127-138
83. Strote J., Lee J.E., and Wechsler H. Increasing MDMA use among college students: results of a national survey. J. Adolesc. Health 30 (2002) 64-72
84. Substance Abuse and Mental Health Services Administration, 2007. Results from the 2006 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293). Rockville, Maryland.
85. Sullivan P.F., Kessler R.C., and Kendler K.S. Latent class analysis of lifetime depressive symptoms in the National Comorbidity Survey. Am. J. Psychiatry 155 (1998) 1398-1406
86. Topp L., Barker B., and Degehardt L. The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug Alcohol Depend. 73 (2004) 33-40
87. Topp L., Hando J., Dillon P., Roche A., and Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 55 (1999) 105-115
88. Uebersax J.S. Latent class analysis of substance abuse patterns. In: Collins L., and Seitz L. (Eds). Advances in Data Analysis for Prevention Intervention Research. NIDA Research Monograph 142 (1994), National Institute on Drug Abuse, Rockville, MD 64-80
89. Vollenweider F.X., Gamma A., Liechti M., and Huber T. Psychological and cardiovascular effects and short-term sequelae of MDMA ("Ecstasy") in MDMA-naïve healthy volunteers. Neuropsychopharmacology 19 (1998) 241-251
90. Von Sydow K., Lieb R., Pfister H., Höfler M., and Wittchen H.-U. Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study. Drug Alcohol Depend. 66 (2002) 147-159
91. Walsh H. My first love-clubbing, house music, and ecstasy. Observ. Music Mag. 6 (2004) 22-27
92. Wier E. Raves: a review of the culture, the drugs and the prevention of harm. Can. Med. Assoc. J. 162 (2000) 1843-1848
93. Winstock A.R., Griffiths P., and Stewart D. Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend. 64 (2001) 9-17
94. Yacoubian G.S. Assessing the temporal relationship between race and ecstasy use among high school seniors. J. Drug Educ. 32 (2002) 213-225
95. Yacoubian G.S., Miller S., Pianim S., Kunz M., Orrick E., Link T., Palacios W.R., and Peters R.J. Toward an ecstasy and other club drug (EOCD) prevention intervention for rave attendees. J. Drug Educ. 34 (2004) 41-59